Element Capital Management LLC Myriad Genetics Inc Transaction History

Element Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$27.23 - $45.56 $251,060 - $420,063	-9,220 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$37.57 - $50.34 $49,103 - $65,794	1,307 Added 16.52%	9,220 $424,000
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $260,406 - $376,955	-9,384 Reduced 54.25%	7,913 $296,000
Q1 2018 May 15, 2018	BUY	$28.83 - $41.01 $498,672 - $709,349	17,297 New	17,297 $511,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.3B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Element Capital Management LLC with notifications on news.